Deleted scene Boyd Haley PhD discusses the efficacy of OSR / NBMI / Irminix / Emeramide
www.youtube.com
Deleted scene from the documentary, Evidence of Harm. Boyd Haley PhD discusses the efficacy of OSR / NBMI / Irminix / Emeramide
  • rtwinOP
    1·
    1 year ago

    https://clinicaltrials.gov/study/NCT04183595

    Status d.d. 2024-02-03: Not Yet Recruiting

    The clinicaltrials website lists the following status’

    • Not yet recruiting: The study has not started recruiting participants.
    • Recruiting: The study is currently recruiting participants.
    • Enrolling by invitation: The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.
    • Active, not recruiting: The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.
    • Suspended: The study has stopped early but may start again.
    • Terminated: The study has stopped early and will not start again. Participants are no longer being examined or treated.
    • Completed: The study has ended normally, and participants are no longer being examined or treated (that is, the last participant’s last visit has occurred).
    • Withdrawn: The study stopped early, before enrolling its first participant.
    • Unknown: A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been last verified within the past 2 years.****
  • lemmybotB
    1·
    1 year ago

    Study Status

    • Record Verification| 2024-03
    • Overall Status | Recruiting
    • Study Start | 2023-11-22 [Actual]
    • Primary Completion | 2024-05-22 [Estimated]
    • Study Completion | 2024-11-22 [Estimated]
    • First Submitted | 2019-06-19
    • First Submitted that Met QC Criteria | 2019-11-28
    • First Posted | 2019-12-03
    • Last Update Submitted that Met QC Criteria | 2024-03-08
    • Last Update Posted | 2024-03-12 [Actual]

    Last changes:

    • Recruitment Status
    • Study Status
    • Contacts/Locations
  • rtwinOP
    1·
    8 months ago

    https://emeramed.com/study-mercury-poisoned-gold-miners/

    Emeramide found to be safe and effective

    This study would indicate that Emeramide is both safe and effective at chelating mercury and thereby reducing the symptoms associated with mercury exposure. In addition to environmental exposure, there are a great many products that still contain mercury and those exposed would likely benefit greatly from a similar round of treatment.

    To read the published study, click here:

    Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial Published: 14 February 2018

  • rtwinOP
    1·
    19 days ago

    Ward Dean MD | Joe Rogan speaking with RFK Jr regarding Mercury & Boyd Haley #NBMI #OSR #WardDeanMD

    https://www.youtube.com/watch?v=mGC2vm1w5tA

    Nov 17, 2024 Joe Rogan speaking with RFK Jr regarding Mercury and Boyd Haley #Ward DeanMD #BoydHaley #joerogan #chelation #mercury

  • rtwinOP
    1·
    18 days ago

    🙏

    From Boyd Haley on 2023-11-08

    EmeraMed is funding a Phase II clinical trial on using NBMI to treat mercury toxicity in gold miners located in Colombia, SA that will take at least 3 months to complete. Hopefully, this study will suffice for FDA approval for marketing authority in the USA. <…>. We are also hopeful that the INVIMA officials will approve NBMI for use in S. American countries after successful completion of our Phsse II study. We have anecdotal results in the USA that NBMI will reduce urinary Hg levels by over 90% with our Phase II treatment with 600 mg NBMI per day.